EMEA-001418-PIP02-15-M03
Key facts
Invented name |
Vocabria
|
Active substance |
Cabotegravir
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0102/2022
|
PIP number |
EMEA-001418-PIP02-15-M03
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Prevention of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
|
Contact for public enquiries |
ViiV Healthcare UK Limited
E-mail: eu.paediatric-plans@gsk.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001418-PIP02-15-M03
|
Compliance opinion date |
20/05/2022
|
Compliance outcome |
positive
|